The role of co-expression of CXC chemokine receptor 2 and interleukin-22 binding protein in gastric adenocarcinoma progression

Shibin Yang,Liang Deng,Longbin Xiao,Mingzhe Li,Fanghai Han,Yulong He

DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2015.11.061

2015-01-01

Abstract:Objective To explore the co-expression of CXC chemokine receptor 2 (CXCR2) and interleukin-22 binding protein (IL-22BP) in gastric adenocarcinoma and the roles in gastric adenocarcinoma (GA) progression.Methods The expression of CXCR2 and IL-22BP was detected by immuohistochemistry and real-time reverse transcriptase-polymerase chain reaction (RT-qPCR) in 112 cases of GA tissues, and the clinical significance was analyzed.Results As compared with non-cancerous tissue, in GA, 82 cases of CXCR2 and 85 cases of IL-22BP proteins were over expression, and were observed in cytoplasm mainly.64 cases of CXCR2 and 60 cases of IL-22BP proteins mRNA levels was analyzed, and co-expression relation was identified.It is significantly higher expression and more positive cases of CXCR2 and IL-22BP proteins were observed with advanced pTNM stage in GA, as well as lymph node metastasis present to absent and deep muscular invasion to superficial (P ＜ 0.05).In a Kaplan-Meier analysis, compared to negative expression, both proteins identified a group of patients with the shortest overall survival (OS).Conclusion CXCR2 and IL-22BP may take part in more complex mechanisms and roles, and indicate poor outcome in GA progression.